Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. LBX Pharmacy Chain Joint Stock Company
  6. News
  7. Summary
    603883   CNE1000023Q8

LBX PHARMACY CHAIN JOINT STOCK COMPANY

(603883)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. from Hainan Qitai Enterprise Management Partnership (Limited Partnership).

09/30/2021 EST

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) entered into an agreement to acquire remaining 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. from Hainan Qitai Enterprise Management Partnership (Limited Partnership) for CNY 10.4 million on July 11, 2021. After the transaction is approved and implemented, LBX Pharmacy need to complete the payment of the equity transfer price as agreed by the two parties after the agreement takes effect, after the completion of the settlement and after the completion of the completion of the acquisition involving all tax and fee payment obligations. Upon completion, LBX Pharmacy will hold 100% stake in Taizhou Longtaiyuan Pharmaceutical. In related transactions, LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. and 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. The transaction was funded by own funds of LBX Pharmacy. The transaction is subject to approval from shareholders of LBX Pharmacy and other possible approvals or approvals (if any) required by relevant laws and regulations. The transaction has been approved by the Board of LBX Pharmacy. As of August 20, 2021, shareholders of LBX Pharmacy Chain Joint Stock Company approved the transaction. Wei Qinghua of Dongxing Securities acted as financial advisor to LBX Pharmacy. Ding Shaobo, Xie Yongjun, Wu Juan, Wang Tianjiao and Zhao Chengjie of Hunan Qiyuan Law Firm acted as legal advisors, Li Dan, Chen Jianxiang and Shen Jing of PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) acted as accountants, Hu Shaoxian, Zhao Jiao and Zhou Ya of Pan-China Certified Public Accountants LLP and Fang Wensen, Chen Zhi and Wang Weihua of Zhongshenhua Certified Public Accountants (Special general partnership) acted as accountants to LBX Pharmacy. Hu Jiahao, He Yuanquan and Xie Songsha of Zhongrui Shilian Assets Appraisal Group Co., Ltd. acted as the appraisers for LBX Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company (SHSE:603883) completed the acquisition of remaining 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. from Hainan Qitai Enterprise Management Partnership (Limited Partnership) on September 30, 2021.


© S&P Capital IQ 2021
All news about LBX PHARMACY CHAIN JOINT STOCK COMPANY
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months End..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of the remaining 35% s..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company agreed to acquire 51% stake in Hebei Hua Tuo Pha..
CI
2021Lbx Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended..
CI
2021LBX Pharmacy Chain Joint Stock Company entered into an agreement to acquire remaining 4..
CI
2021LBX Pharmacy Chain Joint Stock Company entered into an agreement to acquire remaining 4..
CI
2021LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 35% stake in Zhenjia..
CI
2021LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter E..
CI
More news
Financials
Sales 2021 15 780 M 2 497 M 2 497 M
Net income 2021 691 M 109 M 109 M
Net Debt 2021 1 232 M 195 M 195 M
P/E ratio 2021 26,8x
Yield 2021 0,77%
Capitalization 18 447 M 2 918 M 2 918 M
EV / Sales 2021 1,25x
EV / Sales 2022 0,97x
Nbr of Employees -
Free-Float 40,2%
Chart LBX PHARMACY CHAIN JOINT STOCK COMPANY
Duration : Period :
LBX Pharmacy Chain Joint Stock Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LBX PHARMACY CHAIN JOINT STOCK COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 45,41 CNY
Average target price 65,13 CNY
Spread / Average Target 43,4%
EPS Revisions
Managers and Directors
Li Wang President
Jing Yang Zhu Chief Financial Officer
Zi Long Xie Chairman
Cheng Xiang Wang Chairman-Supervisory Board
Zhe Min Dan Independent Director
Sector and Competitors